National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection

被引:12
作者
Bini, Edmund J.
Currie, Sue L.
Shen, Hui
Brau, Norbert
Schmidt, Warren
Anand, Bhupinderjit S.
Cheung, Ramsey
Wright, Teresa L.
机构
[1] VA New York Harbor Healthcare Syst, Div Gastroenterol, New York, NY 10010 USA
[2] NYU, Sch Med, New York, NY USA
[3] VA Med Ctr, San Francisco, CA USA
[4] VA Med Ctr, Boston, MA USA
[5] VA Med Ctr, Palo Alto, CA USA
[6] VA Med Ctr, Iowa City, IA USA
[7] VA Med Ctr, Houston, TX USA
关键词
HIV; AIDS; hepatitis C; testing; multicenter studies; epidemiology;
D O I
10.1097/00004836-200609000-00014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although HIV testing is recommended for persons with hepatitis C virus (HCV) infection who are at risk for HIV, little is known about HIV testing in this population. Methods: Data were prospectively collected in 4364 HCV-infected patients at 24 Veterans Affairs medical centers across the United States, including demographics, risk factors for HIV infection, and self-reported information on HIV testing. Results: Overall, 76.8% had been tested for HIV at least once, 14.8% were never tested, 6.6% did not know if they were tested, and 1.8% declined to answer. Multivariable analysis identified injection drug use, needlestick injury, sex with a same-sex partner, a greater number of lifetime sexual partners, and sex with an injection drug user as factors that were independently associated with HIV testing. At least one risk factor for HIV infection was present in 84.5% of the 646 patients who were never HIV tested. Among the 3350 subjects who were tested for HIV, 8.4% were positive, 88.3% were negative, 2.4% did not know the results of their test, and 0.9% declined to answer. Multivariable analysis identified African American and Hispanic race/ethnicity, income <=$10,000, sex with a same-sex partner, and sex with an injection drug user as the only variables that were independently associated with HIV seropositivity. Conclusions: Although a substantial proportion of HCV-infected patients have been tested for HIV, missed opportunities for early diagnosis of HIV infection exist. Public health strategies to improve HIV testing among patients with chronic HCV infection are needed.
引用
收藏
页码:732 / 739
页数:8
相关论文
共 45 条
[1]   Primary care guidelines for the management of persons infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America [J].
Aberg, JA ;
Gallant, JE ;
Anderson, J ;
Oleske, JM ;
Libman, H ;
Currier, JS ;
Stone, VE ;
Kaplan, JE .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) :609-629
[2]   Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: Data from the HIV Atlanta VA Cohort Study [J].
Anderson, KB ;
Guest, JL ;
Rimland, D .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) :1507-1513
[4]  
[Anonymous], 1999, MMWR, V48, DOI [DOI 10.1037/E547822006-001, 10.1037/e547822006-001]
[5]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[6]   Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].
Bica, I ;
McGovern, B ;
Dhar, R ;
Stone, D ;
McGowan, K ;
Scheib, R ;
Snydman, DR .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497
[7]  
BINI EJ, 2003, CURR HEPATITIS REP, V2, P108
[8]  
Bräu N, 2003, AIDS, V17, P2279, DOI [10.1097/01.aids.0000088176.01779.19, 10.1097/00002030-200311070-00002]
[9]   Prevalence of hepatitis C and coinfection with HIV among United States Veterans in the New York City metropolitan area [J].
Bräu, N ;
Bini, EJ ;
Shahidi, A ;
Aytaman, A ;
Xiao, PY ;
Stancic, S ;
Eng, R ;
Brown, ST ;
Paronetto, F .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08) :2071-2078
[10]  
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1